Ke Wu Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2021	Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis.
12/2020	Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma.
5/2020	Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis.
1/2020	Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma.
1/2020	Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
3/2019	COMMD7 Regulates NF-κB Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells.
2/2019	GSK923295 as a potential antihepatocellular carcinoma agent causing delay on liver regeneration after partial hepatectomy.
1/2018	EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
1/2018	The Role of Exportin-5 in MicroRNA Biogenesis and Cancer.
5/2016	COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ke Wu Research Topics

Disease

75	Neoplasms (Cancer) 06/2022 - 05/2009
20	Colonic Neoplasms (Colon Cancer) 01/2022 - 10/2010
12	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 10/2012
11	Neoplasm Metastasis (Metastasis) 05/2020 - 11/2010
8	Stomach Neoplasms (Stomach Cancer) 01/2020 - 10/2010
8	Insulin Resistance 12/2016 - 08/2004
7	Carcinogenesis 09/2021 - 09/2017
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2013
6	Inflammation (Inflammations) 10/2022 - 04/2011
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 05/2009
5	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 03/2019
4	Hemorrhage 03/2021 - 09/2014
4	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 01/2018
4	Infections 01/2020 - 01/2015
4	Breast Neoplasms (Breast Cancer) 10/2019 - 04/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 05/2009
3	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 01/2019
3	COVID-19 04/2021 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 11/2020 - 01/2020
3	Melanoma (Melanoma, Malignant) 11/2020 - 05/2009
3	Type 2 Diabetes Mellitus (MODY) 09/2020 - 08/2004
3	Hypersensitivity (Allergy) 01/2020 - 01/2020
3	Osteosarcoma (Osteogenic Sarcoma) 09/2019 - 08/2014
3	Obesity 01/2015 - 05/2009
3	Hepatitis B 03/2013 - 07/2012
3	Body Weight (Weight, Body) 10/2010 - 03/2005
3	Hyperglycemia 08/2010 - 12/2007
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 11/2021
2	Adenocarcinoma of Lung 01/2022 - 05/2020
2	Hypertrophy 01/2022 - 03/2021
2	Glucose Intolerance 01/2022 - 03/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 03/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2021 - 10/2016
2	Pathologic Constriction (Stenosis) 04/2021 - 04/2020
2	Silicosis 01/2021 - 11/2019
2	Fibrosis (Cirrhosis) 01/2021 - 11/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 11/2019
2	Plasmacytoma 01/2021 - 01/2020
2	Triple Negative Breast Neoplasms 12/2020 - 07/2018
2	Stroke (Strokes) 11/2020 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2020 - 12/2018
2	Intestinal Obstruction (Obstruction, Intestinal) 01/2020 - 07/2019
2	Lymphatic Metastasis 09/2019 - 11/2010
2	Carcinoma (Carcinomatosis) 02/2019 - 05/2009

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 03/2022 - 08/2004
14	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2004
13	MicroRNAs (MicroRNA)IBA 12/2020 - 10/2015
11	Long Noncoding RNAIBA 12/2020 - 10/2016
10	Biological ProductsIBA 10/2022 - 06/2010
10	Pharmaceutical PreparationsIBA 01/2022 - 08/2010
10	CytokinesIBA 01/2021 - 05/2009
8	Messenger RNA (mRNA)IBA 01/2022 - 10/2010
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2013
6	Insulin (Novolin)FDA Link 08/2010 - 08/2004
5	CateninsIBA 01/2020 - 07/2012
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 09/2005
4	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2016
4	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2018
4	Estrogens (Estrogen)FDA Link 01/2021 - 01/2018
4	oridoninIBA 11/2018 - 08/2014
4	EnzymesIBA 11/2017 - 08/2010
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 08/2004
3	LipidsIBA 07/2021 - 01/2017
3	tetrandrineIBA 05/2021 - 03/2015
3	VaccinesIBA 04/2021 - 03/2013
3	Circular RNAIBA 01/2019 - 09/2017
3	p38 Mitogen-Activated Protein KinasesIBA 11/2018 - 02/2016
3	Sirolimus (Rapamycin)FDA Link 01/2018 - 10/2015
3	ResveratrolIBA 07/2017 - 07/2014
3	Dimenhydrinate (DMH)FDA LinkGeneric 03/2015 - 10/2010
3	DimethylhydrazinesIBA 03/2015 - 10/2010
3	Dextrans (Dextran)FDA Link 03/2015 - 10/2010
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2015 - 10/2010
3	Carrier Proteins (Binding Protein)IBA 07/2012 - 10/2010
3	Polysaccharides (Glycans)IBA 01/2010 - 03/2005
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 04/2017
2	Neuroprotective AgentsIBA 01/2022 - 01/2019
2	LigandsIBA 01/2022 - 01/2018
2	Coenzyme A (CoA)IBA 04/2021 - 06/2013
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2018
2	CollagenIBA 01/2021 - 11/2019
2	astragaloside AIBA 01/2021 - 11/2019
2	InterleukinsIBA 01/2021 - 01/2019
2	Therapeutic UsesIBA 12/2020 - 01/2019
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2020 - 02/2016
2	1-ethyl-2-benzimidazolinoneIBA 01/2020 - 01/2020
2	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2020 - 01/2020
2	Immunologic Factors (Immunomodulators)IBA 01/2020 - 01/2020
2	ApaminIBA 01/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 09/2017
2	Gemcitabine FDA Link 01/2019 - 06/2013

Therapy/Procedure

13	Therapeutics 01/2022 - 02/2004
9	Drug Therapy (Chemotherapy) 06/2022 - 07/2012
4	Immunotherapy 01/2021 - 10/2015
3	Stents 11/2019 - 03/2019
2	Transplantation 12/2021 - 01/2019
2	Operative Time 07/2019 - 06/2018